| IPI00003479 - MAPK1, MITOGEN-ACTIVATED PROTEIN KINASE 1. | |
|---|---|
| Uniprot Accession: Q499G7 | |
| Uniprot ID: Q499G7_HUMAN | |
| Mapping: Chr 22, 20446873 - 20551730 | |
| Entrez Gene: 5594 | |
| Entrez MapView: |
|
| +All IPI Database Cross References | |
| IPI records in this ortholog cluster (Cluster: MGI_ORTHOLOGY_10680) |
|---|
| Rat: Mapk1, MITOGEN-ACTIVATED PROTEIN KINASE 1. |
| Mouse: Mapk1, MITOGEN-ACTIVATED PROTEIN KINASE 1. |
| Mouse: Mapk1, ERK2. |
| Mouse: Mapk1, 16 KDA PROTEIN. |
| Rat: Mapk1, 33 KDA PROTEIN. |
| Human: MAPK1, MITOGEN-ACTIVATED PROTEIN KINASE 1. |
| GO Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| insoluble fraction | C | IDA | ||
| nucleus | C | IEA | IDA IDA IDA | ISS |
| cytosol | C | IDA | ||
| cytoplasm | C | IEA | IDA IDA IDA | ISS |
| protein kinase activity | F | IDA | ISS | |
| kinase activity | F | IDA IDA | TAS ISS | |
| protein-tyrosine kinase activity | F | ISS | ||
| protein binding | F | IPI IPI IPI | IPI IPI IPI | ISS |
| MAP kinase activity | F | TAS | IDA TAS IMP IDA IDA | TAS ISS ISS IEA |
| transferase activity | F | IEA | IEA | IEA |
| protein serine/threonine kinase activity | F | IEA | ISS | IEA |
| phosphotyrosine binding | F | IEA | IMP | ISS |
| ATP binding | F | IEA | IEA IEA | IEA |
| nucleotide binding | F | IEA | IEA | IEA |
| intracellular signaling cascade | P | IDA | ||
| protein kinase cascade | P | TAS | ||
| peptidyl-serine phosphorylation | P | ISS | ||
| response to lipopolysaccharide | P | IEA | IDA | |
| positive regulation of transcription | P | IEP | ||
| synaptic transmission | P | TAS | ISS | |
| response to chemical stimulus | P | IDA | ||
| lipopolysaccharide-mediated signaling pathway | P | IEA | IDA | |
| response to exogenous dsRNA | P | IEA | IDA | |
| protein amino acid phosphorylation | P | IEA | IDA IDA IDA | TAS ISS IEA |
| positive regulation of cell proliferation | P | IEP | ||
| MAPKKK cascade | P | IEA | IDA | ISS |
| cell cycle | P | IEA | IEA | IEA |
| response to stress | P | ISS | ||
| chemotaxis | P | TAS | ISS | |
| induction of apoptosis | P | TAS | ISS | |
| cytosine metabolic process | P | IEA | IDA | ISS |
| signal transduction | P | TAS | TAS | IDA ISS ISS |
| negative regulation of cell differentiation | P | IEA | IGI | |
| sensory perception of pain | P | IMP | ||
| organ morphogenesis | P | IEA | IDA | ISS |
| phosphorylation | P | TAS | ISS | |
| nuclear translocation of MAPK | P | IDA | ||
| positive regulation of cell migration | P | IEP | ||
| response to DNA damage stimulus | P | IEA | IDA | ISS |
| response to estrogen stimulus | P | IDA |
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| MP Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| growth/size phenotype | MP | Un | ||
| homeostasis/metabolism phenotype | MP | Un | ||
| other phenotype | MP | Un | ||
| embryogenesis phenotype | MP | Un Un | ||
| lethality-embryonic/perinatal | MP | Un Un Un | ||
| immune system phenotype | MP | Un | ||
| cardiovascular system phenotype | MP | Un | ||
| hematopoietic system phenotype | MP | Un | ||
| muscle phenotype | MP | Un | ||
| embryonic lethality | N | ISS | ||
| absent extraembryonic ectoderm | N | ISS | ||
| absent ectoplacental cone | N | ISS |
| DO Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| Coronary Restenosis | D | IED | ||
| Cardiomegaly | D | IED | ||
| Myocardial Infarction | D | IED | ||
| Brain Ischemia | D | ISS | ||
| Myocardial Reperfusion Injury | D | IED |
| PW Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| The extracellular signal-regulated RAF/MEK/ERK pathway | W | IDAIMP |
| KEGG Pathway | Human | Mouse | Rat |
|---|---|---|---|
| Glioma (05214) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| GnRH signaling pathway (04912) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Long-term depression (04730) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Chronic myeloid leukemia (05220) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| mTOR signaling pathway (04150) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Toll-like receptor signaling pathway (04620) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| TGF-beta signaling pathway (04350) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Fc epsilon RI signaling pathway (04664) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Adherens junction (04520) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| MAPK signaling pathway (04010) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| VEGF signaling pathway (04370) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Type II diabetes mellitus (04930) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Colorectal cancer (05210) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Regulation of actin cytoskeleton (04810) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Axon guidance (04360) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Gap junction (04540) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Dorso-ventral axis formation (04320) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Pancreatic cancer (05212) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Insulin signaling pathway (04910) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Natural killer cell mediated cytotoxicity (04650) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Focal adhesion (04510) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Long-term potentiation (04720) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |